Background Limited data are available on the long-term effects of contemporary drug-eluting
stents versus contemporary bare-metal stents on rates of death, myocardial infarction, repeat …

Background Recent data have suggested that patients with coronary disease in large
arteries are at increased risk for late cardiac events after percutaneous intervention with first …

Context Although drug-eluting stents reduce restenosis rates relative to bare-metal stents,
concerns have been raised that drug-eluting stents may also be associated with an …

Background Recent reports suggest that off-label use of drug-eluting stents is associated
with an increased incidence of adverse events. Whether the use of bare-metal stents would …

Background The long-term safety and efficacy of drug-eluting coronary stents have been
questioned. Methods We evaluated 47,967 patients in Sweden who received a coronary …

Background—Drug-eluting stents (DES) reduce the need for repeat revascularization, but
their long-term safety relative to that of bare-metal stents (BMS) in general use remains …

Aims To evaluate the effect of drug-eluting vs. bare metal stents for the treatment of coronary
artery disease on overall, cardiac, and non-cardiac mortalities. Methods and results We …

BACKGROUND: Several observational reports have documented both increased and
decreased cardiac mortality or Q-wave myocardial infarction with drug-eluting stents …

Objectives: We investigated the effectiveness and safety of drug-eluting stents (DES) as
used in routine clinical practice. Background: Randomized trials have shown that DES …

Objective: The aim was to compare 2-year outcomes with the routine use of drug-eluting
stents (DES)(> 75%“off-label”) with a comparable group treated with bare-metal stents …